THYMOGLOBULIN

STN# 103869
Proper Name: Anti-thymocyte Globulin (Rabbit)
Tradename: THYMOGLOBULIN
Manufacturer: Genzyme Corporation
Indication:

• THYMOGLOBULIN is indicated for the prophylaxis and treatment of acute rejection in adult and pediatric patients receiving a kidney transplant in conjunction with concomitant immunosuppression.

Product Information

• Package Insert - THYMOGLOBULIN

Supporting Documents

• June 18, 2026 Approval Letter - THYMOGLOBULIN
• January 27, 2026 Approval Letter - THYMOGLOBULIN
• September 27, 2024 Approval Letter - THYMOGLOBULIN
• April 21, 2017 Approval Letter - Thymoglubin
• April 21, 2017 Summary Basis for Regulatory Action - Thymoglobulin
• Supporting Documents older than three years - Thymoglobulin